Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Debt / NOTE 2.000% 8/1
-
Number of holders
-
1
-
Total 13F principal, excl. options
-
52,392,000
-
Principal change
-
-223,530,000
-
Total reported value, excl. options
-
$36,674,000
-
Value change
-
-$158,977,000
-
Number of buys
-
1
-
Number of sells
-
-11
-
Price
-
$0.7000
Significant Holders of AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 as of Q2 2019
12 filings reported holding 00767EAB8 - AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 as of Q2 2019.
AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 has 1 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $52,392,000 of principal
.
Largest 10 bondholders include EdgePoint Investment Group Inc. ($52,392,000 of principal), HIGHBRIDGE CAPITAL MANAGEMENT LLC ($0 of principal), Allianz Asset Management GmbH ($0 of principal), CITIGROUP INC ($0 of principal), EdgePoint Investment Group Inc. ($0 of principal), Stonepine Capital Management, LLC ($0 of principal), Whitebox Advisors LLC ($0 of principal), Athyrium Capital Management, LP ($0 of principal), Context Capital Management, LLC ($0 of principal), and ORBIMED ADVISORS LLC ($0 of principal).
This table shows the top 1 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.